08.Established company under the name “Ubiprotein Co., Ltd.

11.Proceeded with domestic patent application related to the development of protein therapy that applies half-life increase technology

02.Established company research center

10.Proceeded with PCT application related to the development of protein therapy that applies half-life increase technology

10.Incorporated as a subsidiary of “BioPlus Co., Ltd."

Initiated the development of anti-obesity drugs containing GLP-1 variants

06.25Relocated head office and affiliated research center to Munjeong-dong, Songpa-gu, Seoul

08Initiated the development of improved botulinum light chain

09.16Took over the Daejeon plant

12Acquired a license for manufacturing medical devices

Acquired permission to use biomaterials for tissue repair (for export)

01Started filler business